User profiles for S. Bátkai

Sandor Batkai

Cardior Pharmaceutical GmbH
Verified email at cardior.de
Cited by 25168

Evidence for novel cannabinoid receptors

M Begg, P Pacher, S Bátkai, D Osei-Hyiaman… - Pharmacology & …, 2005 - Elsevier
… As mentioned above, the low potency and efficacy of anandamide at the human endothelial
receptor could suggest the existence of endogenous ligand(s) other than anandamide. …

Cardiovascular pharmacology of cannabinoids

P Pacher, S Batkai, G Kunos - Cannabinoids, 2005 - Springer
p]Cannabinoids and their synthetic and endogenous analogs affect a broad range of
physiological functions, including lcardiovascular variables, the most important component of their …

Endocannabinoids as cardiovascular modulators

G Kunos, Z Járai, S Bátkai, SK Goparaju… - Chemistry and physics …, 2000 - Elsevier
Cannabinoids, the bioactive constituents of the marijuana plant and their synthetic and
endogenous analogs cause not only neurobehavioral, but also cardiovascular effects. The most …

Leptin-regulated endocannabinoids are involved in maintaining food intake

V Di Marzo, SK Goparaju, L Wang, J Liu, S Bátkai… - Nature, 2001 - nature.com
Leptin is the primary signal through which the hypothalamus senses nutritional state and
modulates food intake and energy balance 1 . Leptin reduces food intake by upregulating …

[HTML][HTML] Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

…, P Pacher, J Liu, S Radaeva, S Bátkai… - The Journal of …, 2005 - Am Soc Clin Investig
… leptin (Quantikine M; R&D Systems) and adiponectin levels were determined using commercial
sandwich ELISA assays (B-Bridge International) in accordance with the manufacturer’s

Activation of the peripheral endocannabinoid system in human obesity

…, M Feldpausch, K Gorzelniak, J Janke, S Bátkai… - Diabetes, 2005 - Am Diabetes Assoc
… Student’s t test or a paired sample t test was used for group comparisons, as appropriate.
Pearson’s coefficient of correlation and multiple linear regression models with stepwise …

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

…, N Kloting, J Berndt, M Fasshauer, S Bátkai… - Diabetes, 2006 - Am Diabetes Assoc
The endocannabinoid system has been suspected to contribute to the association of
visceral fat accumulation with metabolic diseases. We determined whether circulating …

Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats

P Pacher, T Nagayama, P Mukhopadhyay, S Bátkai… - Nature protocols, 2008 - nature.com
… of the cuvette (guides provided by manufacturer may be used), quickly submerge it in the
blood (all 4 electrodes should be submerged) and hold it as steady as possible for 10–20 s in …

[HTML][HTML] Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

J Tam, VK Vemuri, J Liu, S Bátkai… - The Journal of …, 2010 - Am Soc Clin Investig
… Unpaired 2-tailed Student’s t test was used to determine differences between vehicle- and
compound-treated groups. Time-dependent variables were analyzed, and results in multiple …

Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy

…, S Bátkai, V Patel, K Saito, S Matsumoto… - Journal of the American …, 2010 - jacc.org
Objectives : In this study, we have investigated the effects of cannabidiol (CBD) on myocardial
dysfunction, inflammation, oxidative/nitrative stress, cell death, and interrelated signaling …